Back to top

ChemoCentryx Inc Enters Oversold Territory

Read MoreHide Full Article

ChemoCentryx Inc. ’s (CCXI - Free Report) share price has entered into oversold territory with an RSI value of 28.52. The Zacks Consensus Estimate on CCXI’s loss for the full year period has moved lower by 12 cents over the past two months to $1.03 per share. Currently, ChemoCentryx Inc. is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (CCXI - Free Report) after its recent drop.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ChemoCentryx, Inc. (CCXI) - free report >>

More from Zacks Tale of the Tape

You May Like